Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains
ALAMEDA, Calif., April 23, 2024 /PRNewswire/ -- Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced a partnership with NYtor B.V (The Netherlands), an innovative assay developer, to create a rapid, accurate, pen-side test that will detect the dominant swine flu strains, including H1N1, H1N2 and H3N2.
- If a group of infected pigs are brought into a new facility, the virus can spread rapidly through susceptible swine.
- Even worse, newly infected swine could be moved to additional facilities, spreading swine flu throughout the new destination.
- The Alveo platform, including its mobile app, Alveo Sense , is a rapid, handheld, reusable, and rugged multiplexed molecular diagnostic device.
- NYtor is developing swine flu assays for the Alveo platform that will enable operations to monitor the flu status of their animals in real time with rapid, highly accurate pen-side tests.